Brodalumab: an evidence-based review of its potential in the…
Established
24
Citations88
Refs2014
Year
Search Works
Work Details
- DOI 10.2147/ce.s33940
- PMID https://pubmed.ncbi.nlm.nih.gov/25093016
- PMCID https://www.ncbi.nlm.nih.gov/pmc/articles/4112723
- OpenAlex ID W2120639068
- Type Review
- Language EN
- Published 01 Jul 2014
- Volume 9
- Pages 89
- Source Core evidence
- Publisher Dove Medical Press
- FWCI 0.52
- Countries 1
- Institutions 5
- Added 24 Jun 2016
- Updated 01 Nov 2026
External Links
MENU
0
Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis
Review 2014 EN Diamond
Advances in knowledge regarding the pathogenesis of psoriasis have allowed the development of a new class of agents known as biologic drugs. Data confirm that T helper (Th)17 and interleukin (IL)-17 signaling has a crucial role in the pathogenesis of the disease. High levels of IL-17 and Th17-related cytokines have been reported in psoriasis, leading to the suggestion of agents targeting IL-17 as…
24
Citations
88
References
3
Authors
0.52
FWCI
Citations by Year
Last 8 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
3 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Susana Coimbra Corresponding | Universidade do Porto (PT) Cooperativa de Ensino Superior… (PT) +1 | |
| 2 | Alice Santos‐Silva Corresponding | Universidade do Porto (PT) Instituto de Biologia Molecula… (PT) | |
| 3 | Américo Figueiredo | Unidade Local de Saúde de Coim… (PT) University of Coimbra (PT) |
Related Works
10Data: OpenAlex